Sciwind Biosciences is a drug research and development company for metabolic diseases. Founded in 2017, Sciwind Biosciences is backed by investors that include Kawin Technology, Legend Capital, and Shiyu Capital. Sciwind Biosciences is headquartered in Hangzhou.